Neonatal Bilirubin Levels | Advanced Instruments
We are open and continue to provide essential lab supplies during the COVID-19 pandemic. Answers to your FAQs can be found here. Read More

Bilirubin Levels in Newborns

Neonatal bilirubin is a yellow breakdown product of normal heme catabolism in newborns. Its levels are elevated in certain diseases and responsible for the yellow color of bruises.

Risk to Newborns

Hyperbilirubinemia is one of the most common problems encountered in term newborns. Up to 60% of term newborns have clinical jaundice in the first week of life. Excessive bilirubin damages developing brain cells in infants (kernicterus) and may cause mental retardation, learning and developmental disabilities, hearing loss, or eye movement problems. It is important that bilirubin levels in newborns not get too high. When the level of bilirubin is above a critical threshold, special treatments are initiated to lower it.

High Bilirubin Levels are Common in Newborns

High bilirubin levels in newborns are relatively common, especially within three days of birth. This is sometimes called physiologic jaundice of the newborn. Within the first 24 hours of life, up to 50% of full-term newborns, and an even greater percentage of pre-term babies, may have a high bilirubin level. After birth, newborns begin breaking down the excess red blood cells (RBCs) they are born with and, since the newborn’s liver is not fully mature, it is unable to process the extra bilirubin, causing levels to rise in the blood and other body tissues. This situation usually resolves itself within a few days.

Principle of Operation

The Advanced Model BR2 Bilirubin Stat-Analyzer™ measures Total Bilirubin (TBR) and Direct Bilirubin (Azobilirubin) absorbance quantitatively per deciliter. It determines total bilirubin by spectrophotometric analysis and direct bilirubin using a modified version of the proven Malloy-Evelyn method.

Total Bilirubin – The maximum light absorption of bilirubin occurs at a wavelength of 454 nm. Oxyhemoglobin (HbO2) has nearly equal absorbance at 454 and 540 nm. In the BR2, the absorbance at 540 nm (HbO2) is subtracted from the absorbance at 454 nm (TBR + HbO2). The remainder corresponds to TBR concentration corrected for oxyhemoglobin up to 600 mg/dL. Light from an incandescent source is collimated and directed through a cuvette containing the diluted sample. A fiber optic beam splitter with 454-nm and 540-nm channels splits the transmitted light, each made monochromatic by a narrow-bandpass interference filter. Matched solid-state photo-detectors and signal processing electronics measure the transmittances at 454 and 540 nm and display the TBR concentration digitally.

Direct Bilirubin – Direct Bilirubin is measured as the change in absorbance at 540 nm due to the formation of azobilirubin, using a two-minute, timed-endpoint modification to the Malloy and Evelyn method. After TBR has been measured on a sample, that same sample is acidified with HCl, establishing an absorbance baseline. Next, diazotized sulfanilic acid is added. Under these conditions, the conjugated (Direct) bilirubin fraction will react to form azobilirubin, which has maximum light absorption at 540 nm. At the end of the two-minute reaction period, the digital display locks in to hold the DBR readout until the next test is initiated.

See Advanced Instruments’ full range of neonatal bilirubin analyzers.